Navigating the Badger State: A Deep Dive into Wisconsin's Healthcare Regulatory Landscape for Expanding Practices

2026-06-20

Expanding into Wisconsin requires a precise understanding of its regulatory framework: a fee-splitting statute instead of an explicit corporate practice ban, Medical Examining Board telemedicine rules that forbid questionnaire-only prescribing, and a mandatory prescription drug monitoring check. This guide sets out what the rules say and how to build around them.

Wisconsin offers real opportunities for telehealth companies and practices looking to expand. Beneath that promise lies a regulatory environment that rewards careful structuring. For any healthcare business considering operations in the Badger State, understanding Wisconsin's specific rules is essential.

> For more on this topic, see our analysis: Navigating the North Star State: A Comprehensive Guide to Minnesota Healthcare Compliance.

The Nuance of Corporate Practice of Medicine (CPOM) in Wisconsin

Unlike states that write a corporate practice prohibition into their medical practice statutes, Wisconsin reaches the same concerns more indirectly. The core principle is the same: licensed practitioners must keep their independent medical judgment, and unlicensed individuals or entities must not control clinical decisions or the delivery of professional services.

Wisconsin Statutes Chapter 448, which governs physicians and other medical professions, and the rules of the Medical Examining Board (MEB) under the Department of Safety and Professional Services (DSPS) frame how medical businesses are organized. Physicians may practice through service corporations (S.C.), and the professional services must be rendered by a duly licensed individual. In practice this means:

Prohibition on Lay Control: Unlicensed individuals or entities should not dictate clinical decisions, set employment terms that compromise a clinician's judgment, or otherwise interfere with the physician-patient relationship.
Fee-Splitting Restrictions: Wis. Stat. § 448.08(1m) provides that, except as otherwise provided in that section, a licensee may not give or receive any fee, commission, rebate or other form of compensation or anything of value for the referral of a patient, or in connection with professional services not actually rendered personally or at the licensee's direction. The section also requires separate billing, permits single bills from bona fide physician partnerships and service corporations that identify each person who rendered the services, and allows physicians to work as employees of hospitals and medical education and research organizations under contracts that let the physician exercise professional judgment without supervision or interference (§ 448.08(5)). Management fees are a common point of scrutiny for management services organizations (MSOs).
Aiding and Abetting Unlicensed Practice: Facilitating or allowing an unlicensed individual to engage in activities reserved for licensed professionals exposes the licensees involved to discipline.

What this means for your structure: Wisconsin permits several business structures, but any arrangement involving non-licensed owners must be vetted so that licensed professionals retain authority over clinical care, compensation flows do not reward referrals, and nothing could be construed as unlicensed practice. This usually means an MSO model that separates administrative services from clinical decision-making, with a management fee tied to documented services rather than to referrals.

Navigating Wisconsin's Telehealth Frontier

The Medical Examining Board's telemedicine rules, Wis. Admin. Code ch. Med 24, set the framework for physicians. Telemedicine has the meaning of "telehealth" in Wis. Stat. § 440.01(1)(hm) (Med 24.02, as revised effective June 1, 2025).

Licensure Requirements: A physician who uses telemedicine in the diagnosis and treatment of a patient located in Wisconsin must be licensed by the Medical Examining Board (Med 24.04). Out-of-state physicians must secure Wisconsin licensure before treating Wisconsin patients.
Establishing the Patient-Provider Relationship: A physician-patient relationship may be established through telemedicine (Med 24.03).
Standard of Care: A physician practicing by telemedicine is held to the same standards of practice and conduct as in person, including confidentiality and recordkeeping (Med 24.05), and is responsible for the quality and safe use of the equipment (Med 24.06).
Website-Based Care and Prescribing: A physician who uses a website to communicate with a patient in Wisconsin may not provide treatment recommendations, including a prescription, unless the physician is licensed in Wisconsin, the physician's name and contact information are available to the patient, informed consent is obtained under Wis. Stat. § 448.30 and ch. Med 18, a documented patient evaluation has been performed, and a health care record is kept under ch. Med 21 (Med 24.07(1)). Treatment recommendations or prescriptions based only on a static electronic questionnaire do not meet the standard of minimally competent medical practice (Med 24.07(2)).
Technology and Security: Telehealth services should be delivered on platforms that protect patient privacy and meet HIPAA's security requirements.

Prescribing in the Badger State: A Focus on Controlled Substances

Prescribing practices, particularly for controlled substances, draw close scrutiny in Wisconsin, in line with national efforts to combat opioid misuse.

Wisconsin Enhanced Prescription Drug Monitoring Program (WI ePDMP): Wis. Stat. § 961.385(2)(cs) requires that a patient's PDMP records be reviewed, by the practitioner or the practitioner's agent, before the practitioner issues a prescription order for a monitored prescription drug. The exceptions are hospice patients, a supply of 3 days or less that cannot be refilled, a drug lawfully administered to the patient, an emergency that makes review impossible, and a PDMP outage or other technological failure that is reported to the Controlled Substances Board. The statute sets this requirement to end on April 1, 2030.
Telehealth and Controlled Substances: Wisconsin's telemedicine rules apply to controlled substances as to any other prescription: a Wisconsin license, a documented evaluation, informed consent and a complete record, and never a prescription based only on a static questionnaire. At the federal level, the in-person evaluation normally required before prescribing controlled substances by telemedicine is currently relaxed by the DEA and HHS fourth temporary extension of telemedicine flexibilities (90 FR 61301, published December 31, 2025), which lets DEA-registered practitioners prescribe controlled medications by telemedicine without a prior in-person evaluation, subject to the rule's conditions, through December 31, 2026. A program that depends on remote controlled substance prescribing should plan now for whatever DEA puts in place after that date.

Building a Compliant Wisconsin Operation

For operators planning a Wisconsin launch:

Structure ownership around § 448.08. Use a licensed clinical entity for professional services, keep clinical decisions with clinicians, and set management fees for documented services, never for referrals.
License before you treat. Every physician treating a patient located in Wisconsin needs a Wisconsin license.
Build intake around a documented evaluation. Do not prescribe from a static questionnaire; capture informed consent and keep a complete record under ch. Med 21.
Hard-wire the PDMP check. Put the WI ePDMP review into the prescribing workflow for every monitored prescription drug, and document any exception that applies.
Track the federal telemedicine deadline. Revisit controlled substance workflows before December 31, 2026.

Scope Your Wisconsin Program

Wisconsin's rules are workable for operators who build them into the structure and the clinical workflow from day one. If you are bringing a telehealth or multi-site program into the state, scope your program with TrueEval and we will map the clinical coverage and compliance structure it needs.